logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Pharmaceutical Intermediates > Quetiapine Fumarate CAS 111974-72-2

Quetiapine Fumarate CAS 111974-72-2

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 111974-72-2

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15DAY

Payment Terms: L/C,D/A,D/P,T/T,Western Union,MoneyGram

Supply Ability: G,KG,TON

Get Best Price
Highlight:
Appearance::
White Crystalline Solid
CAS NO::
111974-72-2
Molecular Formula::
C46H54N6O8S2
Molecular Weight::
883.08600
EINECS NO::
601-144-2
MDL NO::
MFCD03423782
Appearance::
White Crystalline Solid
CAS NO::
111974-72-2
Molecular Formula::
C46H54N6O8S2
Molecular Weight::
883.08600
EINECS NO::
601-144-2
MDL NO::
MFCD03423782
Quetiapine Fumarate CAS 111974-72-2

Product Description:

Product Name: Quetiapine fumarate CAS NO: 111974-72-2


Synonyms:

2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol hemifumarate;

Quetiapine Hemifumarate;

Quetiapine hemifumarate salt;


Chemical & Physical Properties:

Appearance: White crystalline solid

Assay :≥99.00%

Boiling Point: 556.5℃ at 760 mmHg

Melting Point: 174-176℃

Flash Point: 290.4℃

Vapor Pressure: 3.22E-13mmHg at 25℃


Safety Information:

RTECS: PC1075000

Hazard Class: 3

Safety Statements: S53; S45

HS Code: 2934999090

Packing Group: III

WGK Germany: 3

RIDADR: UN 3295 3/PG 3

Risk Statements: R45; R10

Hazard Codes: T; F;N;Xn

Hazard Declaration: H302; H400

Caution Statement: P273

Symbols: GHS07, GHS09

Signal Word: Warning


Used as an antipsychotic. Benzothiazepine with mixed serotonin and dopamine receptor antagonistic properties. Quetiapine fumarate is an atypical antipsychotic used in the treatment of schizophrenia, bipolar I mania, bipolar II depression, bipolar I depression.IC50 value: Target: 5-HT ReceptorQuetiapine is indicated for the treatment of schizophrenia as well as for the treatment of acute manic episodes associated with bipolar I disorder. The antipsychotic effect of quetiapine is thought by some to be mediated through antagonist activity at dopamine and serotonin receptors. Specifically the D1 and D2 dopamine, the alpha 1 adrenoreceptor and alpha 2 adrenoreceptor, and 5-HT1A and 5-HT2 serotonin receptor subtypes are antagonized. Quetiapine also has an antagonistic effect on the histamine H1 receptor.


If you are interested in our products or have any questions, please feel free to contact us!


Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.